PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Polyether Polyketides”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources

Stereoselective synthesis of the western hemisphere of salinomycin.

[structure: see text]. A convergent and module-based strategy for the asymmetric synthesis of the western hemisphere (C1-C17 fragment) of salinomycin has been devised. This new synthetic approach relies on highly stereoselective C-glycosidation and aldol processes.

Aldehydes↗

Investigations by HPLC-electrospray mass spectrometry and NMR spectroscopy into the isomerisation of salinomycin.

HPLC-MS studies have indicated that certain polyether ionophore veterinary drugs are prone to degradation when stored as water-methanol solutions at ambient temperature. Salinomycin and narasin were particularly susceptible, disappearing completely within weeks to produce more polar species, which were identified as isomers of the original compounds. Lasalocid appeared to be stable under such conditions. Structural elucidation of the principal ultimate salinomycin isomerisation product was achieved by 2D NMR spectroscopy. This indicated that the isomerisation process consists of the opening of the spiro rings in the salinomycin structure with the concomitant formation of a furan moiety. The MS data indicated that the isomers retain the ability to complex alkali metal ions and may therefore retain their pharmacological activity. These discoveries may have implications both for the development of legislation covering acceptable levels of polyether ionophore residues in foodstuffs and also for analytical protocols designed to detect them.

Anti-Bacterial Agents↗

18O-Labelling pattern of okadaic acid from H218O in dinoflagellate Prorocentrum lima elucidated by tandem mass spectrometry.

Okadaic acid is a metabolite of the unicellular algae dinoflagellate. Its biosynthesis has attracted considerable attention since the skeletal structure was shown to be synthesized via an unprecedented route. However, its relevant intermediates or enzymes are unknown. In the course of our previous investigations on the oxygen source of okadaic acid by tandem mass spectrometry (CID MS/MS), we determined the level of 18O incorporation for each oxygen site from 18O2 and [18O2]acetate. In the present study, we examined H218O-labelling patterns of okadaic acid from dinoflagellates in comparison with salinomycin from actinomycetes and has provided intriguing information regarding biosynthesis. Unexpectedly, oxygen atoms originating from acetate were not labelled from H218O; this can not be accounted for by the usual metabolic route where acetyl-CoA is biosynthesized via pyruvate. Similar experiments for salinomycin revealed that all of its oxygen atoms derived from acetate or propionate were labelled by H218O. Another interesting feature is that two oxygen sites were derived from both O2 and H2O while the others were labelled only from O2. These results imply that an oxidation mechanism other than those in actinomycetes polyethers may be involved in the biosynthesis of okadaic acid.

Animals↗

The effect of salinomycin on health status and performance of sows and their litters: a dose titration study.

Two hundred and fifty gilts and sows (Dalland parent stock) were divided randomly and allocated into the following five experimental groups: SAL0 = negative controls, SAL20 = 20 mg salinomycin per kg of feed, SAL40 = 40 mg salinomycin per kg of feed, SAL60 = 60 mg salinomycin per kg of feed and SAL80 = 80 mg salinomycin per kg of feed. Each gilt and sow was allocated to one of the five groups after the confirmation of the pregnancy using the ultrasonic method and remained under treatment for two consecutive breeding cycles. Throughout the experimental period several parameters related to sow health status, performance and fertility, as well as to health status and performance of their litters were recorded and calculated. Results indicated that salinomycin improves most of the parameters examined, as it leads to significantly higher (P < 0.05): (i) sow body weight gain during gestation; (ii) number of piglets born alive and weaned; (iii) piglet body weight at birth and at weaning, as well as to significantly lower (P < 0.05): (i) prevalence of thin sow syndrome at weaning; (ii) sow body weight loss during lactation; (iii) weaning-to-oestrus interval; (iv) piglet diarrhoea score during lactation; and (v) preweaning mortality. The best results were obtained at the inclusion levels of 40 and 60 mg salinomycin per kg of feed.

Animal Feed↗

The effect of salinomycin on certain blood parameters and milk quality of lactating sows.

Twenty-five gilts and sows, after pregnancy confirmation using the ultrasonic method, were randomly divided and allocated to the following five experimental groups: SAL0 = negative controls, SAL20 = 20 mg salinomycin per kg of feed, SAL40 = 40 mg salinomycin per kg of feed, SAL60 = 60 mg salinomycin per kg of feed and SAL80 = 80 mg salinomycin per kg of feed. All animals remained under treatment for two consecutive breeding cycles. The sows were fed a home-mixed balanced feed during gestations and lactations. At the third, tenth and eighteenth day of each lactation, blood and milk samples were collected. Blood samples were analysed for cholesterol and total lipids and milk samples were analysed for the determination of the fat, lactose, protein, ash and totals solids concentrations. In all treated groups, cholesterol concentrations were significantly higher (P < 0.05) compared with the controls. Total lipid concentrations were significantly higher (P < 0.05) in SAL40 and SAL60 groups in comparison with SAL0 and SAL20 groups, during both cycles. Milk fat concentrations were higher (P < 0.05) in treated groups than in the control group; the highest concentrations were observed at SAL40 and SAL60 groups. In all treated groups, concentrations of milk lactose were significantly higher (P < 0.05) than those observed in the negative control group. Milk protein concentrations were significantly higher (P < 0.05) in SAL40 and SAL60 groups compared with the SAL0 group, but there was no significant difference in SAL20 and SAL80 groups in comparison with the SAL0 group. No significant differences were observed concerning milk ash concentrations between all groups. In all treated groups, concentrations of total solids were significantly higher (P < 0.05) in comparison with the control group; the highest concentrations were observed in the SAL40 and SAL60 groups. It is concluded that the use of salinomycin in sow diet, increases concentrations of blood triglycerides and cholesterol and improves the quality of milk, thus reflecting on higher weight gain and survival rate of suckling piglets.

Animal Feed↗

Combined effect of salinomycin and feeding on whole body glucose kinetics in sheep fed a high-concentrate diet.

The aim of this study was to investigate the effects of salinomycin (SL) and feeding on whole body glucose kinetics in sheep fed a high-concentrate diet (25% orchardgrass hay and 75% commercial concentrate). Four adult sheep were fed the diet with or without 20 mg x kg(-1) diet of SL once daily for each 3 wk. The rates of glucose entry and utilization were determined before and during 3 h after feeding using a [ (13)C(6)] glucose dilution approach. Ruminal characteristics and concentrations of blood volatile fatty acids (VFA) and plasma glucose and insulin were also measured. Metabolizable energy intake was unaffected (P = 0.22) with SL. Salinomycin decreased (P = 0.06) the ratio of acetate to propionate in rumen fluid. Salinomycin increased (P = 0.01) both rates of entry and utilization of glucose, but did not affect (P > 0.10) concentrations of blood VFA or plasma glucose or insulin. Feeding caused gradual increases in concentrations of blood acetate (P < 0.01) and propionate (P = 0.01), a transient increase in plasma insulin concentration (P = 0.05), a transient decrease in plasma glucose concentration (P < 0.01), and persistent increases in both rates of glucose entry (P < 0.01) and utilization (P < 0.01). No SL x feeding interaction was observed (P > 0.10) on any measurements. We conclude that SL and feeding would have an additive effect on both rates of glucose entry and utilization without modifications with SL to feeding responses of peripheral concentrations of blood VFA, plasma glucose and insulin.

Animal Feed↗

Efficacy of toltrazuril in broilers and development of a laboratory model for sensitivity testing of Eimeria field isolates.

(1) The efficacy of toltrazuril (Baycox) against coccidiosis was established on a broiler farm in an intermittent application during five consecutive growing periods. Treated birds were fed a broiler ration without anticoccidials. The efficacy of Baycox was compared with the nicarbazin-salinomycin shuttle. It was concluded that Baycox retarded the onset of Eimeria infection for several weeks. During the fifth rearing period coccidiosis problems emerged on the farm in all birds during medication, suggesting development of resistance. (2) During a laboratory experiment the efficacy of Baycox was studied in birds after inoculation with different numbers of oocysts at 7, 10 or 15 days of age. Baycox was applied at 10 and 11 days of age. In all cases medication with Baycox protected birds from coccidiosis during a period of at least 7 days. This effect of Baycox could be due to the long-existing tissue levels of the product and its metabolites as well as its specific effect on the second generation of schizonts. (3) In another laboratory experiment coccidia obtained from field trials were tested for sensitivity to Baycox in conjunction with two strains obtained from farms were coccidiosis emerged during application. The inoculation model developed in this study was used for sensitivity testing. One of the Eimeria strains tested was resistant to the product, one strain was tolerant and the remaining two strains, including the control strain, were fully sensitive to Baycox.

Animals↗

Incidence of residues of nine anticoccidials in eggs.

A survey of the presence of residues of anticoccidials was performed. Three hundred and twenty egg samples, purchased in eight different European countries, were analysed for the presence of nine different compounds: dimetridazole, diclazuril, halofuginone, robenidine, nicarbazin, narasin, salinomycin, lasalocid and monensin. Analyses were performed by LC-MS/MS. Of the samples analysed, 114 (35.6%) contained one or more of the nine anticoccidials in concentrations ranging from 0.1 to 63 microg kg-1. Salinomycin and lasalocid account for more than 60% of all positive samples. Almost 90% of all positive samples contained less than 2 microg kg-1. Results were put into perspective of the farming method and country of origin.

Animal Husbandry↗

Simultaneous determination of four coccidiostats in eggs and broiler meat: validation of an LC-MS/MS method.

A published confirmatory method for the quantitative determination of four ionophoric coccidiostats (lasalocid, monensin, salinomycin and narasin) in eggs and broiler meat has been further developed. It is proposed for replacement of liquid chromatography methods previously used in analysis of ionophoric coccidiostats. The samples were extracted with acetonitrile and purified on a silica solid phase extraction column. Purified samples were analysed by liquid chromatography-mass spectrometry and the method, was validated according to the Commission Decision 2002/657/EC. The validation parameters selectivity, linearity, specificity, precision, recovery, decision limit (CCalpha) and detection capability (CCbeta) were determined. The recoveries of coccidiostats analysed ranged from 64-99% in eggs and 62-100% in broiler meat. CCalpha varied from 0.8-1.4 microg/kg in eggs and from 1.5-2.5 microg/kg in broiler meat. CCbeta varied from 0.9 microg/kg to 2.0 microg/kg in eggs and from 1.7-3.2 microg/kg in broiler meat.

Animals↗

Development of an ELISA for salinomycin and depletion kinetics of salinomycin residues in poultry.

Salinomycin is widely used as a feed additive to control coccidiosis in the broiler industry world-wide. EC legislation on veterinary drug residues will soon be extended to cover poultry. This will require the development of rapid assays to screen for the presence of residual concentrations of this and other drugs in poultry meat. This study describes the development of an enzyme-linked immunosorbent assay for salinomycin that has a limit of detection of approximately 0.2 ng/g. The antibody cross-reacts with narasin, but is not subject to interference from lasalocid, maduramicin or monensin. Residual concentrations of salinomycin were measured in the tissues of broilers following feeding of medicated feed containing 60 mg/kg salinomycin. Salinomycin residues were present only at very low concentrations in liver and muscle, and fell below the limit of decision of the assay within 2 days of withdrawal of the medicated feed.

Animals↗

Determination of ionophores in the tissues of food animals by liquid chromatography.

A liquid chromatographic method for determining residues of ionophores in bovine, porcine, and avian tissues is described. Tissues were extracted with iso-octane-ethyl acetate and the extracts purified on silica solid-phase extraction columns. Monensin, narasin and salinomycin were detected by UV absorbance following post-column derivatization with vanillin, and lasalocid was detected underivatized using fluorescence. In muscle, kidney and fat, all drugs were determined from a single sample extract. In liver, a separate extraction was done to determine lasalocid. The detection limit for lasalocid, narasin and salinomycin was 5 ppb; for monensin it was 2 ppb. Average recoveries were: lasalocid-71.0%; monensin-94.3%; salinomycin-97.2%; narasin-94.1%.

Adipose Tissue↗

Concentrations of salinomycin in eggs and tissues of laying chickens fed medicated feed for 14 days followed by withdrawal for 3 days.

Laying chickens were fed medicated feed containing various concentrations of sodium salinomycin (SAL) for 14 days followed by a 3 day withdrawal period. Eggs, collected during treatment and withdrawal, tissues and ovarian yolk of birds slaughtered after 0, 1, and 3 days' withdrawal were extracted and analysed by high performance liquid chromatography (HPLC). Tissues, ovarian yolk and freeze-dried egg albumen and yolk were extracted with acetone, followed by partitioning with petroleum ether and HPLC analysis. Albumen was extracted with methanol and analysed without further clean-up. Salinomycin was detected at 520 nm after post-column reaction with vanillin at 95 degrees C. Recoveries of fortified salinomycin from freeze-dried eggs (albumen and yolk) and tissue, premix and feed were nearly quantitative (> 90%), except liver which was < 85%. The detection limit was estimated to be 5 ng g-1, with the practical quantifiable limit being about 10 ng g-1. Highest SAL concentrations were in the more fatty components such as egg yolk, ovarian yolk and subcutaneous fat. SAL residues in other tissues were generally low and followed the order liver, kidney, thigh and breast muscles. SAL residues were dependent on the SAL concentration in feed and declined rapidly during withdrawal.

Administration, Oral↗

Ionophore residues in eggs in Northern Ireland: incidence and cause.

Monensin, salinomycin and narasin were detectable in six, two and one, respectively, out of 161 eggs surveyed in Northern Ireland in 1994. In all cases, the concentrations detected were less than 2.5 ng/g. Lasalocid was detectable in 107 eggs at concentrations ranging from 0.3 to 129 ng/g. Cross-contamination of unmedicated feeds with monensin during feed manufacture (up to eight batches of unmedicated feed contaminated with monensin) was similar to that previously observed for lasalocid (up to nine batches contaminated). Therefore differences in the incidence in eggs could not be explained by differential carry-over during feed manufacture. In a feeding trial it was shown that the relative ability of monensin, salinomycin and lasalocid to accumulate in eggs was in the ratio 0.12:3.3:63 ng/g egg per mg/kg feed, respectively. This indicated that the potential for monensin and salinomycin to cause residues in eggs was very low, by comparison with lasalocid. In 1995, a granular formulation of the lasalocid premix was introduced into the United Kingdom that decreased the carry-over of this drug from medicated to unmedicated feed. Six months after the introduction of this formulation, the incidence of lasalocid residues in eggs (21%) was lower than that found (66.5%) in an earlier survey (1994) carried out, and published, by this laboratory.

Animal Feed↗

Microwave extraction of incurred salinomycin from chicken tissues.

A rapid, accurate, environmentally friendly and cost-effective microwave extraction technique was developed for the extraction of spiked and incurred salinomycin from chicken tissues (kidney, liver, muscle, ovarian yolk and fat). Extraction of salinomycin from various tissues was achieved by irradiating the sample in absolute ethanol and 2-propanol (15 + 2) for 9 sec. in a common household microwave oven. The extract was analysed without further cleanup by HPLC on a C18 column (5 microns) and detected at 592 nm via post-column reaction with 4-dimethylaminobenzaldehyde (DMABA) in a heated reactor coil at 86 degrees C. Recoveries of salinomycin from spiked tissues at 30 ng/g level ranged between 87 and 100%. The limit of quantitation was found to be 10 ng/g. The developed method was applied for the analysis of incurred tissues and ovarian yolk of laying chickens given sodium salinomycin in feed at different levels for 14 consecutive days followed by withdrawal periods. Residues were detected in all tissues and ovarian yolk at 0 withdrawal time but declined during the withdrawal period. Highest residue were found in fat and ovarian yolk.

Animals↗

Comparative investigation of salinomycin and flavophospholipol in sheep fed different composed diets.

The effects of salinomycin and flavophospholipol, and their relationship with the diet, were studied in nine ruminally and duodenally cannulated wethers. Within the composition of the ration, the levels of rumen degradable protein (RDP) and non-structural carbohydrates (NSC) were changed (diet H: 74% RDP and 38% NSC; diet M: 57% RDP and 32% NSC; diet L: 48% RDP and 23% NSC). There was no clear treatment effect of flavophospholipol on propionate concentration. Salinomycin supplementation appeared to be more effective than flavophospholipol in the increase of propionate concentration at the expense of acetic acid. Salinomycin significantly reduced the ammonia concentration of the rumen fluid. Microbial N content of the duodenal digesta was significantly lower when salinomycin was used. Salinomycin inhibited proteolysis and reduced the efficiency of microbial protein synthesis. The effect of salinomycin on ruminal N metabolism was independent of the composition of substrate. Unlike salinomycin, flavophospholipol tended to increase proteolysis in the rumen and did not inhibit protein synthesis. The effect of salinomycin on ruminal fermentation and the duodenal flow of nutrients were independent of substrate composition.

Animal Feed↗

Effect of dietary zinc level on serum carotenoid levels, body and shank pigmentation of chickens after experimental infection with coccidia.

Two experiments were conducted to test the effects of a dietary zinc amino acid complex (Zn-AA) and an anticoccidial drug on Eimeria acervulina or Eimeria tenella infections. In each experiment, 288 day-old Three-Yellow-Chickens were used in a 2 x 3 factorial experimental design. Six groups were arranged randomly to receive three levels of Zn-AA (0, 40, or 80 mg/kg) alone or with salinomycin (60 mg/kg). Additionally an uninfected group was set as negative control. At the age of 21 days birds in Exp. 1 were inoculated with 3 x 10(4) sporulated E. acervulina oocysts, while birds in Exp. 2 were inoculated with 1.5 x 10(4) sporulated E. tenella oocysts. In Exp. 1, E. acervulina did not suppress growth performance significantly, but in groups without salinomycin it significantly reduced serum carotenoid levels on day 7 after inoculation and body and shank pigmentation on day 42. Salinomycin medication maintained serum carotenoids and visual colour of inoculated birds, but Zn-AA did not influence these parameters. In Exp. 2, growth performances of infected and uninfected chickens were similar. Infection decreased to only serum carotenoid levels on day 14 after infection, and colour scores on day 42 in the inoculated group without salinomycin and Zn-AA supplementation. The birds that received Zn-AA had significantly higher serum carotenoid levels and colour scores than those that did not. Although supplementation of Zn-AA cannot avoid coccidial damage of caecum, it prevents the reduction of serum carotenoids and pigmentation of Three-Yellow-Chicken infected with E. tenella, but not after infection with E. avervulina. The interactive effects between Zn-AA and salinomycin on growth performance and pigmentation were not significant.

Amino Acids↗